Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV trial of three intravenous furosemide dosing schedules in acute decompensated chronic heart failure
2008-004488-20Phase 4Active
- Sponsor
- Hospital General Universitario de Alicante
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of furosemide in heart failure (HF) and chronic heart failure (CHF) (3 arms), sponsored by Hospital General Universitario de Alicante. Primary endpoint: Mean diuresis after 24 hours. Started Feb 2010; status: active.
02
Drugs
furosemide
03
Conditions
heart failure (HF)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2008-004488-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004488-20.